Page last updated: 2024-10-15

inosine dialdehyde

Description

inosine dialdehyde: do not confuse synonym ''diglycolaldehyde'' with synonym of same name for oxydiacetaldehyde (C4H603); RN given refers to (R-(R*,R*))-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135400916
CHEMBL ID1998222
SCHEMBL ID2557589
MeSH IDM0050561

Synonyms (28)

Synonym
nsc-118994
9h-purine-9-acetaldehyde,6-dihydro-6-oxo-, (r,r)-
23590-99-0
diglycolaldehyde, .alpha.-(hydroxymethyl)-.alpha.'-(6-hydroxy-9h-purin-9-yl)-
9h-purine-9-acetaldehyde,6-dihydro-6-oxo-, (r-(r*,r*))-
nsc118994
inox
nsc 118994
inosine dialdehyde
(r,r)-alpha-(1-formyl-2-hydroxyethoxy)-1,6-dihydro-6-oxo-9h-purine-9-acetaldehyde
alpha-(hydroxymethyl)-alpha'-(6-hydroxy-9h-purin-9-yl) diglycolaldehyde
9h-purine-9-acetaldehyde, alpha-(1-formyl-2-hydroxyethoxy)-1,6-dihydro-6-oxo-, (r,(r*,r*))-
diglycoaldehyde
9h-purine-9-acetaldehyde, alpha-(1-formyl-2-hydroxyethoxy)-1,6-dihydro-6-oxo-, (r,r)-
NCI60_000456
4613t5zy7g ,
unii-4613t5zy7g
CHEMBL1998222
SCHEMBL2557589
ribox
9h-purine-9-acetaldehyde, .alpha.-(1-formyl-2-hydroxyethoxy)-1,6-dihydro-6-oxo-, (r,r)-
9h-purine-9-acetaldehyde, .alpha.-((r)-1-formyl-2-hydroxyethoxy)-1,6-dihydro-6-oxo-, (.alpha.r)-
9h-purine-9-acetaldehyde, .alpha.-(1-formyl-2-hydroxyethoxy)-1,6-dihydro-6-oxo-, (r-(r*,r*))-
(2r)-3-hydroxy-2-[(1r)-2-oxo-1-(6-oxo-6,9-dihydro-1h-purin-9-yl)ethoxy]propanal
(r)-3-hydroxy-2-((r)-2-oxo-1-(6-oxo-1h-purin-9(6h)-yl)ethoxy)propanal
Q27258885
DTXSID901135037
(alphar)-alpha-[(r)-1-formyl-2-hydroxyethoxy]-1,6-dihydro-6-oxo-9h-purine-9-acetaldehyde
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (76.92)18.7374
1990's1 (7.69)18.2507
2000's0 (0.00)29.6817
2010's1 (7.69)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (6.25%)0.25%
Other13 (81.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]